Evidence map›Paper›PMID 17130481›Full record

ArticleDiabetes2006

Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene.

Juliette Gray, Giles S H Yeo, James J Cox, Jenny Morton, Anna-Lynne R Adlam, Julia M Keogh, Jack A Yanovski, Areeg El Gharbawy, Joan C Han, Y C Loraine Tung and 4 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Diabetes, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 229 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
229citing papers in PubMed, 6 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

229 citing papers in PubMed, 6 syntheses or guidelines pooled it, 510 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. FTO predicts weight regain in the Look AHEAD clinical trial.International journal of obesity (2005) · 2013
    Trial
  9. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial.The American journal of clinical nutrition · 2012
    Trial
  10. Review
  11. Management of Childhood Obesity.International journal of molecular sciences · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

169 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Juliette GrayUniversity Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, CB2 2XY, U.K.
Giles S H Yeo
James J Cox
Jenny Morton
Anna-Lynne R Adlam
Julia M Keogh
Jack A Yanovski
Areeg El Gharbawy
Joan C Han
Y C Loraine Tung
John R Hodges
F Lucy Raymond
Stephen O'rahilly
I Sadaf Farooqi
Addenbrooke's Hospital · GBEunice Kennedy Shriver National Institute of Child Health and Human Development · USBirmingham Women's Hospital · GBMedical Research Council · GB

Funding

Physiology, Psychology, and Genetics of ObesityZ01HD000641 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI YANOVSKI, JACK A. · 1996 to 2008
$4.6M
Intramural NIH HHS Z01 HD000641Intramural NIH HHS Z99 HD999999Medical Research Council G9724461Medical Research Council G9824984Medical Research Council MC_U105559861Wellcome Trust 068086
6 · The paper itself

Abstract

The neurotrophin brain-derived neurotrophic factor (BDNF) inhibits food intake, and rodent models of BDNF disruption all exhibit increased food intake and obesity, as well as hyperactivity. We report an 8-year-old girl with hyperphagia and severe obesity, impaired cognitive function, and hyperactivity who harbored a de novo chromosomal inversion, 46,XX,inv(11)(p13p15.3), a region encompassing the BDNF gene. We have identified the proximal inversion breakpoint that lies 850 kb telomeric of the 5' end of the BDNF gene. The patient's genomic DNA was heterozygous for a common coding polymorphism in BDNF, but monoallelic expression was seen in peripheral lymphocytes. Serum concentration of BDNF protein was reduced compared with age- and BMI-matched subjects. Haploinsufficiency for BDNF was associated with increased ad libitum food intake, severe early-onset obesity, hyperactivity, and cognitive impairment. These findings provide direct evidence for the role of the neurotrophin BDNF in human energy homeostasis, as well as in cognitive function, memory, and behavior.

Indexed as

Chromosome AberrationsMutationAdultBrain-Derived Neurotrophic FactorChromosome InversionChromosomes, Artificial, BacterialCognition DisordersDNAFemaleHumansHyperkinesisHyperphagiaObesityBrain-Derived Neurotrophic FactorDNA

Identifiers

PMID17130481
PMCPMC2413291
OpenAlexW2161649767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.